Get started
Author

Ryuta Shigefuku

Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma
2020 · Yasuyuki Tamai, Motoh Iwasa, et al. · PLoS ONE · 65
PDF
Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans
2022 · Yasuyuki Tamai, Akiko Eguchi, et al. · eLife · 38
Correlations of Hepatic Hemodynamics, Liver Function, and Fibrosis Markers in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis Related to Hepatitis C Virus
2016 · Ryuta Shigefuku, Hideaki Takahashi, et al. · International Journal of Molecular Sciences · 34
PDF
Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?
2012 · Ryuta Shigefuku, Hideaki Takahashi, et al. · Journal of Gastroenterology · 33
Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus‐related liver cirrhosis
2019 · Ryuta Shigefuku, Motoh Iwasa, et al. · Hepatology Research · 25
Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients
2023 · Ryosuke Sugimoto, Motoh Iwasa, et al. · Frontiers in Medicine · 23
A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis
2022 · Akiko Eguchi, Motoh Iwasa, et al. · Hepatology Communications · 21
Cirrhosis improvement to alcoholic liver fibrosis after passive abstinence
2014 · Hideaki Takahashi, Ryuta Shigefuku, et al. · BMJ Case Reports · 16
Impact of resistance‐associated variant dominancy on treatment in patients with HCV genotype 1b receiving daclatasvir/asunaprevir
2016 · Hiroki Ikeda, Tsunamasa Watanabe, et al. · Journal of Medical Virology · 15
Evaluation of Hepatic Tissue Blood Flow Using Xenon Computed Tomography with Fibrosis Progression in Nonalcoholic Fatty Liver Disease: Comparison with Chronic Hepatitis C
2014 · Ryuta Shigefuku, Hideaki Takahashi, et al. · International Journal of Molecular Sciences · 15
PDF
Accuracy of carbohydrate‐deficient transferrin as a biomarker of chronic alcohol abuse during treatment for alcoholism
2021 · Tatsuya Suzuki, Akiko Eguchi, et al. · Hepatology Research · 14
Fusobacterium nucleatum detected simultaneously in a pyogenic liver abscess and advanced sigmoid colon cancer
2017 · Ryuta Shigefuku, Tsunamasa Watanabe, et al. · Anaerobe · 14
Xenon computed tomography can evaluate the improvement of hepatic hemodynamics before and after endoscopic injection sclerotherapy
2013 · Hideaki Takahashi, Michihiro Suzuki, et al. · Journal of Gastroenterology · 13
The prognostic role of controlling nutritional status and skeletal muscle mass in patients with hepatocellular carcinoma after curative treatment
2022 · Yasuyuki Tamai, Motoh Iwasa, et al. · European Journal of Gastroenterology & Hepatology · 12
Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience
2021 · Motoh Iwasa, Ryuta Shigefuku, et al. · JGH Open · 12
Use of Antithrombin and Thrombomodulin in the Management of Disseminated Intravascular Coagulation in Patients with Acute Cholangitis
2013 · Kazunari Nakahara, Chiaki Okuse, et al. · Gut and Liver · 12
Hepatocellular Carcinoma Pseudoprogression Involving the Main Portal Vein, Right Ventricular Invasion, and Exacerbation of Lung Metastases in a Patient on Atezolizumab Plus Bevacizumab
2022 · Ryuta Shigefuku, Kyoko Yoshikawa, et al. · Internal Medicine · 11
PDF
Serum copeptin level is a biomarker associated with ascites retention and the formation of a portosystemic shunt in chronic liver disease
2020 · Ryuta Shigefuku, Motoh Iwasa, et al. · Journal of Gastroenterology and Hepatology · 11
Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol
2024 · Michihiro Iwaki, Takashi Kobayashi, et al. · BMJ Open · 10
PDF
Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study
2022 · Masanori Atsukawa, Akihito Tsubota, et al. · Hepatology International · 10
PDF
Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b
2016 · Nobuyuki Matsumoto, Hiroki Ikeda, et al. · PLoS ONE · 10
PDF
A Novel Endoscopic Papillectomy After a Pancreatic Stent Placement Above the Pancreatic Duct Orifice
2013 · Kazunari Nakahara, Chiaki Okuse, et al. · Journal of Clinical Gastroenterology · 10
Membranous Nephropathy Associated with Chronic Hepatitis B Occurring in a Short Period After Acute Hepatitis B Virus Infection
2010 · Kazunari Nakahara, Hideaki Takahashi, et al. · Internal Medicine · 10
PDF
Effectiveness of 1-year pemafibrate treatment on steatotic liver disease: the influence of alcohol consumption
2024 · Motoh Iwasa, Ryosuke Sugimoto, et al. · European Journal of Gastroenterology & Hepatology · 9
Esophagogastric varices were diagnosed in a non-cirrhotic liver case during long-term follow-up after oxaliplatin-based chemotherapy
2018 · Ryuta Shigefuku, Tsunamasa Watanabe, et al. · Clinical Journal of Gastroenterology · 9
Works count: 74
Citation count: 555
H-index: 13
I10-index: 23
Year
Topic
Type